 |
|
 |
01. 27 |
³Ø»çƾÁÖ¿ë¾×(¿Á»ì¸®Çöóƾ:Ç×¾ÏÁ¦) Çã°¡ |
|
02. 01 |
³×¿À½ººê(Èí¼ö¼º ºÀÇÕ»ç) Çã°¡ |
|
 |
02. 27 |
Á¦8ȸ ´ëÇѹα¹½Å¾à°³¹ß»ó ¿ì¼ö»ó ¼ö»ó |
|
02. 01 |
Á¦³Ø¼ÖÇÇ¿¥ÁÖ Ãâ½Ã |
|
 |
12. 20 |
´ë´öÀÇ¾à°øÀå ÁõÃà Âø°ø |
|
12. 14 |
2006 º¸°Ç»ê¾÷¿ì¼ö±â¼ú´ëÀü¿¡¼ Á¦³Ø¼Ö-PM ¡®º¸°Çº¹ÁöºÎÀå°ü»ó¡¯ ¼ö»ó ¹×
¡®¿¬±¸¼º°úȰ¿ëÃËÁø ¿ì¼ö±â°ü¡¯À¸·Î (ÁÖ)»ï¾ç»ç ¼±Á¤ |
|
09. 15 |
º¸°Ç»ê¾÷ÁøÈï¿ø ÁÖÃÖ ¡®2006³âµµ ÇØ¿Ü±â¼úÀÌÀü Áö¿ø»ç¾÷¡¯ Á¦³Ø¼ÖÇÇ¿¥ÁÖ ¼±Á¤ |
|
09. 01 |
³×¿À¼Òºê ºÀÇÕ»ç Ãâ½Ã |
|
07. 21 |
Á¦³Ø¼ÖÇÇ¿¥ÁÖ Æó¾Ï ½ÃÆÇÇã°¡ ½ÂÀÎ |
|
07. 11 |
Á¦³Ø¼ÖÇÇ¿¥ÁÖ À¯¹æ¾Ï ½ÃÆÇÇã°¡ ½ÂÀÎ |
|
05. 03 |
'2006 ¹ÙÀÌ¿À»ê¾÷È ±â¼ú°³¹ß»ç¾÷' Á¦³Ø¼ÖÇÇ¿¥ÁÖ ¼±Á¤ |
|
01. 01 |
»ï¾ç»ç ÀǾàÁ¤º¸½Ã½ºÅÛ ±¸Ãà |
|
 |
12. 30 |
´ÏÄÚ½ºÅ¾Æ®·ÎŰ Ãâ½Ã |
|
11. 17 |
´ÏÄÚ½ºÅ¾Æ®·ÎŰ ǰ¸ñÇã°¡ Ãëµæ |
|
11. 16 |
³Ø»çƾÁÖ Ç°¸ñÇã°¡ Ãëµæ |
|
07. 13 |
´ë´öÀÇ¾à°øÀå ÁõÃà Áذø |
|
06. 01 |
¸ð³ëÆÐ½ºÆ® ºÀÇÕ»ç Ãâ½Ã |
|
03. 01 |
¹Ì±¹ Akina, Inc.¿Í Cetirizine FDT, "Business Agreement" ü°á |
|
 |
08. 30 |
±¹³» Çö´ë¾àǰ°ø¾÷¢ß¿Í ¿°»ê Cetirizine FDT "R&D Agreement" ü°á |
|
06. 14 |
Á¦³Ø¼ÖPM À¯¹æ¾ÏII 2»ó ¼¿ï¾Æ»êº´¿ø µî¿¡¼ Àӻ󰳽à |
|
03. 10 |
¸ð³ë¼Òºê-ÇÁ·Î ºÀÇÕ»ç ǰ¸ñÇã°¡ Ãëµæ |
|
02. 23 |
Á¦³Ø¼ÖÁÖ»çÁ¦ À§¾Ï ÀûÀÀÁõ Ãß°¡ |
|
 |
12. 30 |
¹Ì±¹ Akina, Inc.¿Í "R&D Agreement" ü°á |
|
08. 21 |
Á¦³Ø¼ÖPM ºñ¼Ò¼¼Æ÷Æó¾Ï 2»ó ¼¿ï´ëº´¿ø µî¿¡¼ Àӻ󰳽à |
|
02. 21 |
Á¦³Ø¼ÖPM À¯¹æ¾ÏI 2»ó ¼¿ï´ëº´¿ø µî¿¡¼ Àӻ󰳽à |
|
02. 14 |
Á¦³Ø¼ÖÁÖ»çÁ¦ ³¼Ò¾Ï ÀûÀÀÁõ Ãß°¡ |
|
 |
12. 19 |
±×¸®½º Lavipharm»ç¿¡°Ô ´ÏÄÚ½ºÅ¾ ±â¼úÀÌÀü, "R&D Agreement" ü°á |
|
06. 10 |
Á¦³Ø¼ÖÁÖ»çÁ¦ Æó¾Ï ÀûÀÀÁõ Ãß°¡ |
|
05. 30 |
ÀǾ࿬±¸¹ýÀÎ SRC¼³¸³ (¹Ì±¹ À¯Å¸ÁÖ) |
|
03. 27 |
³¿ë¼º¾à¹°ÇÔÀ¯ ½Ã½ºÅÛ Æ¯Çã±â¼ú»ó Áö¼®¿µ»ó ¼ö»ó(ƯÇãû, Áß¾ÓÀϺ¸) |
|
02. 01 |
Á¦³Ø¼Ö-PM ¹Ì±¹ IND Çã°¡ Ãëµæ |
|
 |
10. 06 |
Á¦³Ø¼Ö-PM ÁÖ»çÁ¦ 100mg ǰ¸ñÇã°¡ Ãëµæ |
|
06. 11 |
¹Ì±¹ Akina, Inc.¿Í "Business Agreement" ü°á |
|
03. 30 |
Á¦³Ø¼Ö-PM ÁÖ»çÁ¦ 30mg ǰ¸ñÇã°¡ Ãëµæ |
|
03. 16 |
Á¦³Ø¼ÖÁÖ»çÁ¦ À¯¹æ¾Ï ÀûÀÀÁõ Ãß°¡ |
|
 |
08. 30 |
¹Ì±¹ Transform Pharmaceuticals, Inc.¿Í "R&D Agreement" ü°á |
|
08. 30 |
¹Ì±¹ Transform Pharmaceuticals, Inc.¿Í "Business Agreement" ü°á |
|
08. 30 |
½áÁö¼Òºê, ¹ÙÀÌ¿À¸Þ½¬ CE mark ȹµæ |
|
03. 17 |
¹Ì±¹ MacroMed, Inc.¿Í hGH, pGH, Tramadol, G-CSF, "R&D Agreement" 3°Ç |
|
|